Elsevier

Regulatory Peptides

Volume 56, Issues 2–3, 14 April 1995, Pages 167-174
Regulatory Peptides

Regular paper
In vivo central actions of rat amylin

https://doi.org/10.1016/0167-0115(95)00009-ZGet rights and content

Abstract

The purpose of the present study was to examine and compare the profile of neurobehavioral effects of rat amylin (r-amylin) and rat calcitonin gene-related peptide (rCGRP), two peptides having a 50% structural homology. The effects of synthetic r-amylin and rCGRP administered in several doses (0.312–80.0 μg) into the lateral cerebro-ventricle of rats on spontaneous activity, muscular tone, body temperature, nociception, food intake as well as their potential for inducing catalepsy, were investigated. Intraventricular administration of r-amylin or rCGRP significantly reduced spontaneous motor activity and markedly increased body temperature of animals in a dose-dependent related fashion. rCGRP produced a significant increase in muscular tone and induced cataleptic effect in animals, but r-amylin had no effect on these variables. Furthermore, neither r-amylin nor rCGRP were able to induce any significant effect on nociceptive response time of animals in the tail immersion test even with doses as large as 80.0 μg. Finally, the two peptides did not affect ad libitum food intake, but significantly reduced food consumption in 22 h food-deprived animals. Together, the results of the present study suggest that amylin may be involved in a diversity of neurophysiological processes but displays a different profile of neurobehavioral effects to that of CGRP which may involve different receptors.

References (36)

  • A. Pecile et al.

    Calcitonin gene-related peptide: antinociceptive activity in rats, comparison with calcitonin

    Regul. Pept.

    (1987)
  • T.J. Rink et al.

    Structure and biology of amylin

    Trends Pharmacol. Sci.

    (1993)
  • T. Sanke et al.

    An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing

    J. Biol. Chem.

    (1988)
  • R.A. Silvestre et al.

    Reversal of the inhibitory effects of calcitonin gene-related peptide (CGRP) and amylin on insulin secretion by the 8–37 fragment of human CGRP

    Biochem. Pharmacol.

    (1993)
  • G. Skofitsch et al.

    Quantitative distribution of calcitonin-gene-related-peptide in the rat central nervous system

    Peptides

    (1985)
  • G.C. Zhu et al.

    Amylin increases cyclic AMP formation in L6 myocytes calcitonin generelated peptide receptors

    Biochem. Biophys Res Commun.

    (1991)
  • S.G. Amara et al.

    Alternative RNA processing in calcitonin gene-related expression generates mRNAs encoding different polypeptide products

    Nature

    (1982)
  • R.F.L. Bates et al.

    Comparison of the antinociceptive effects of centrally administered calcitonin and calcitonin gene-related peptide

    Br. Pharm. Soc.

    (1984)
  • Cited by (0)

    View full text